The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 01, 2019
Filed:
Jul. 28, 2016
Applicant:
Esteve Pharmaceuticals, S.a., Barcelona, ES;
Inventors:
Monica Garcia-Lopez, Barcelona, ES;
Carmen Almansa-Rosales, Barcelona, ES;
Ana Virginia Llorente-Fernandez, Barcelona, ES;
Lourdes Garriga-Sanahuja, Barcelona, ES;
Ute Christmann, Barcelona, ES;
Assignee:
ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/04 (2006.01); C07D 309/06 (2006.01); C07D 305/06 (2006.01); C07D 311/96 (2006.01); C07D 295/13 (2006.01); C07D 213/75 (2006.01); C07D 211/26 (2006.01); C07D 409/14 (2006.01); C07D 405/12 (2006.01); C07D 417/14 (2006.01); C07D 409/12 (2006.01); C07D 307/54 (2006.01); C07D 333/38 (2006.01); C07D 277/46 (2006.01); C07D 213/38 (2006.01); C07D 295/192 (2006.01); C07D 487/04 (2006.01); A61P 25/04 (2006.01); C07D 405/14 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 295/12 (2006.01); C07D 295/125 (2006.01); C07D 295/135 (2006.01);
U.S. Cl.
CPC ...
C07D 405/04 (2013.01); A61P 25/04 (2018.01); C07D 211/26 (2013.01); C07D 213/38 (2013.01); C07D 213/75 (2013.01); C07D 277/46 (2013.01); C07D 295/12 (2013.01); C07D 295/125 (2013.01); C07D 295/13 (2013.01); C07D 295/135 (2013.01); C07D 295/192 (2013.01); C07D 305/06 (2013.01); C07D 307/54 (2013.01); C07D 309/06 (2013.01); C07D 311/96 (2013.01); C07D 333/38 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 417/14 (2013.01); C07D 487/04 (2013.01);
Abstract
The present invention relates to substituted amide derivatives having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opioid receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.